Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 63 64 65 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
LabVantage Solutions Inc.. (12/18/12). "Press Release: Süd-Chemie Migrates from SQL*LIMS to Labvantage 6". Somerset, NJ. 2012-12-18
4SC AG. (12/17/12). "Press Release: 4SC Discovery and BioNTech Announce Exclusive Research and License Agreement for 4SC’s TLR Agonists for Cancer Immunotherapy". Planegg-Martinsried & Mainz. 2012-12-17
Evotec AG. (12/17/12). "Press Release: Evotec Announces NMDA Antagonist License Agreement". Hamburg. 2012-12-17
Vivalis S.A.. (12/16/12). "Press Release: Proposed Merger of Equals between Vivalis and Intercell. Creation of a European Biotech Leader in Vaccines and Antibodies [Not for Distribution in Australia, Canada, Japan or the United States]". Nantes & Vienna. 2012-12-16
MorphoSys AG. (12/16/12). "Press Release: Bio-Rad to Acquire MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec. MorphoSys to Increase Focus on Therapeutics". 2012-12-16
Basilea Pharmaceutica Ltd.. (12/14/12). "Press Release: Basilea Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-threatening Fungal Infections". Basel. 2012-12-14
Fresenius SE & Co. KGaA. (12/14/12). "Press Release: Fresenius Announces Decision on Biotechnology Business". Bad Homburg v. d. H.. 2012-12-14
Cube Biotech GmbH. (12/13/12). "Press Release: Startup Cube Biotech Attracts Financing from Creathor Venture". 2012-12-13
Sanochemia Pharmazeutika AG. (12/13/12). "Pressemitteilung: Öffentliches Angebot der Unternehmensanleihe beendet". Wien. 2012-12-13
Biocartis S.A.. (12/12/12). "Press Release: Biocartis Completes €34.5 Million ($44.5 Million) Series D Fund Raising". Lausanne. 2012-12-12
4SC AG. (12/12/12). "Press Release: 4SC Announces Positive Interim Results from Clinical Phase I/II Trial with Anti-cancer Compound Resminostat in Colorectal Cancer". Planegg-Martinsried. 2012-12-12
Roche. (12/12/12). "Press Release: Roche to Invest 240 Million Swiss Francs in Diagnostics Production in Germany. New Penzberg Production Facility Will Help Meet Rising Demand for Diagnostic Products". Basel. 2012-12-12
Wilex AG. (12/12/12). "Press Release: Wilex Inc. Signs Distribution Agreement with Immundiagnostik AG for D-A-CH Region". Munich & Bensheim. 2012-12-12
CLC bio A/S. (12/12/12). "Press Release: CLC bio Part of $7.8m EU STATegra Grant to Develop Integral Analysis Platform for Epigenetics". Aarhus. 2012-12-12
Biotest AG. (12/11/12). "Press Release: Biotest AG Signs Strategically Significant Agreement to Market Human Albumin in China". Dreieich. 2012-12-11
Scienion AG. (12/11/12). "Press Release: Scienion’s sciFlexarrayer Used for the Production of Anagnostics’ Integrated Sepsis Testing Products". Dortmund & St. Valentin. 2012-12-11
Boehringer Ingelheim. (12/11/12). "Press Release: Boehringer Ingelheim Discontinues Phase II Trial in Patients with Artificial Heart Valves [For Non-US, Non-UK & Non-Canadian Media Only]". Ingelheim. 2012-12-11
Basilea Pharmaceutica Ltd.. (12/10/12). "Press Release: Basilea Appoints Ronald Scott as CEO to Succeed Anthony Man and Expands Management Team". Basel. 2012-12-10
Bruker Corporation. (12/10/12). "Press Release: Bruker Announces Multiple Placements of MALDI Biotyper Systems with Various German Federal, State and Local Government Authorities". Bremen. 2012-12-10
PDC Biotech GmbH. (12/10/12). "Press Release: PDC Biotech GmbH Announces Successful Clinical Phase I for Its Lead Compound PDC31". Vienna. 2012-12-10
Anagnostics Bioanalysis GmbH. (12/10/12). "Press Release: Anagnostics Enters Sales Cooperation with Analis S.A. for Belgium and Luxembourg". 2012-12-10
High-Tech Gründerfonds Management GmbH. (12/10/12). "Press Release: Easily Improving Efficiency. Sota Solutions Receives Seed Investment". Berlin, Bielefeld & Bonn. 2012-12-10
Universität Stuttgart. (12/10/12). "Pressemitteilung: Uni Stuttgart und Oncomatrix starten Forschungskooperation. Neue Krebsmedikamente für die Behandlung metastasierender Tumore". 2012-12-10
Biognosys AG. (12/7/12). "Press Release: Closing of Financing Round and New CEO". 2012-12-07
University of Mainz (Johannes-Gutenberg-Universität, JGU). (12/7/12). "Press Release: Launch of the EU Large-scale Integrating Project »BlueGenics« to Combat Osteoporosis". 2012-12-07
Universität Mainz. (12/7/12). "Pressemitteilung: Ausgründungen aus der Universitätsmedizin Mainz feiern Richtfest des neuen Mainzer Biotech-Forschungszentrums". 2012-12-07
Agilent Technologies Inc.. (12/6/12). "Press Release: Agilent Technologies Announces New Version of Intelligent System Emulation Technology, Emulating Waters Alliance LC Systems". Santa Clara, CA. 2012-12-06
Merck KGaA. (12/6/12). "Press Release: Constantin Fest to Head Merck Investor Relations". Darmstadt. 2012-12-06
RainDance Technologies, Inc.. (12/6/12). "Press Release: MLL Munich Leukemia Laboratory Pairs RainDance ThunderStorm System with Illumina MiSeq for Acute Myeloid Leukemia Sequencing". Lexington, MA & Munich. 2012-12-06
Sygnis Pharma AG. (12/6/12). "Press Release: Sygnis Announces Completion of the X-Pol Biotech Acquisition. Registration of the Transaction and the Previous Capital Reduction (Ratio 8:1) in the Commercial Register". Heidelberg. 2012-12-06
Uniqure B.V.. (12/6/12). "Press Release: Uniqure Appoints Hans Christian Rohde Chief Commercial Officer". Amsterdam. 2012-12-06
European ScreeningPort GmbH. (12/6/12). "Press Release: European ScreeningPort Receives Funding for IMI Call4 – Understanding and Optimising Binding Kinetics in Drug Disocvery". Hamburg. 2012-12-06
Max Planck Society for the Advancement of Science. (12/6/12). "Press Release: Grand Opening of Max Planck Florida Institute in the USA". 2012-12-06
Boehringer Ingelheim. (12/5/12). "Press Release: Boehringer Ingelheim and Apexigen Sign Manufacturing Agreement for Process Development and Early Stage Clinical Supply". Ingelheim. 2012-12-05
Roche. (12/5/12). "Press Release: Roche and the Innovative Medicines Initiative Join Forces to Promote Use of Nobel Prize-winning Stem Cell Technology to Enhance Drug Development". Basel. 2012-12-05
Biocartis S.A.. (12/5/12). "Press Release: Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform". Lausanne. 2012-12-05
Biobase GmbH. (12/5/12). "Press Release: ANNOVAR Appoints Biobase for Commercial Distribution". 2012-12-05
Apeiron Biologics AG. (12/4/12). "Press Release: Apeiron Biologics Establishes Biotech-spinoff Attoquant Diagnostics". Vienna. 2012-12-04
Wilex AG. (12/4/12). "Press Release: Wilex AG Announces Restructuring". Munich. 2012-12-04
Epigenomics AG. (12/4/12). "Press Release: Epigenomics AG Reports Non-inferiority of Blood-based Epi proColon against Fecal Immunochemical Testing in Detection of Colorectal Cancer in a Head-to-Head Comparative Study". Berlin & Seattle, WA. 2012-12-04
Sirion Biotech GmbH. (12/4/12). "Press Release: Adeno-associated Virus Now Easily Available for Research and Preclinical Studies". Munich, Bielefeld & Heidelberg. 2012-12-04
Analytik Jena AG. (12/3/12). "Press Release: Analytik Jena Acquires a Stake in Japanese Company Techno X". Jena & Osaka. 2012-12-03
Partec GmbH. (12/1/12). "Press Release: Dramatic Cost Reduction of the Lifelong Immune Status Monitoring of HIV/AIDS Patients. Diganostic Support by More than 3 Million Tests per Year – 1000th CyFlow Counter II Device Manufactured by Partec". Cape Town & 2012-12-01
Austrian Drug Screening Institute. (11/30/12). "Press Release: High Content Screening with Tailored Clinically Relevant Assays". Innsbruck. 2012-11-30
Imperial College London. (11/30/12). "Press Release: National Phenome Research Facility to Open at Imperial. The MRC-NIHR Phenome Centre Will Open at Imperial College London". 2012-11-30
Agennix AG. (11/30/12). "Press Release: Agennix AG Reports Financial Results for Third Quarter and First Nine Months of 2012". Planegg & Princeton, NJ. 2012-11-30
Agennix AG. (11/30/12). "Press Release: Agennix AG Reports Additional Talactoferring Alfa Data". Planegg & Princeton, NJ. 2012-11-30
Helmholtz-Zentrum für Infektionsforschung (HZI. (11/30/12). "Press Release: Concentrated Competencies in the Fight against Infectious Diseases. HZI and the Robert Koch Institute Sign Collaboration Agreement". 2012-11-30
Bayer AG. (11/29/12). "Press Release: European Innovative Medicines Initiative (IMI) – Bayer Supports Pharmaceutical Research in Europe. Bayer HealthCare and Leiden University Coordinate Consortium to Optimize Binding Kinetics for Drug Candidates". Berl 2012-11-29
COMPACT Consortium. (11/29/12). "Press Release: Launch of COMPACT. An Innovative Medicines Initiative Project for Biopharmaceuticals". Brussels, Frankfurt et al.. 2012-11-29
Helmholtz-Zentrum für Infektionsforschung (HZI. (11/29/12). "Press Release: HZI Part of COMPACT. Public-private Partnership for Research of New Pharmaceutics". 2012-11-29
Ipsogen S.A.. (11/29/12). "Press Release: Ipsogen to Be Renamed Qiagen Marseille on the First of January 2013. Results of the General Assembly of 14 November 2012 – Perspectives for 2013". Marseille. 2012-11-29
KWS Saat AG. (11/29/12). "Press Release: KWS Kicks Off Fiscal 2012/2013 with Double-digit Growth in Net Sales, Net Sales Rise by 22% to €113.1 Million – Brazil Contributes to Revenue for the First Time". 2012-11-29
Lonza Group Ltd.. (11/29/12). "Press Release: Lonza Signs Definitive Agreement for the Sale of Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-11-29
Medigene AG. (11/29/12). "Press Release: Medigene and Nordic Pharma Enter into an Agreement for Commercialization of Veregen in Eastern European and CIS Countries. First Market Launches Are Scheduled for 2013". Martinsried. 2012-11-29
Evotec AG. (11/28/12). "Press Release: Evotec Enters Biology Collaboration with Probiodrug". Hamburg. 2012-11-28
ACIB GmbH – Austrian Centre of Industrial Biotechnology. (11/28/12). "Press Release: Biotechnology Connects Slovenia and Austria". 2012-11-28
Bayer AG. (11/28/12). "Press Release: Bayer Completes Recruitment of First Cohort for Novel Recombinant Factor VIIa (rFVIIa) Protein Phase II/III Study [Not intended for U.S. and UK Media]". Berlin. 2012-11-28
DKFZ (Deutsches Krebsforschungszentrum). (11/28/12). "Press Release: Multiplexion Assures Quality of Research Results. Spinout from German Cancer Research Center Checks Cell Cultures for Contamination". 2012-11-28
Max Planck Society for the Advancement of Science. (11/28/12). "Press Release: Max Planck Society Establishes a New Institute in Hamburg. The Hanseatic City Is Set to Become International Centre for Structured Research". 2012-11-28
Qiagen N.V.. (11/28/12). "Press Release: Qiagen Gains SFDA Approval to Market careHPV Test in China – Expanding Access to HPV Testing in Low-resource Countries". Shenzhen & Hilden. 2012-11-28
Roche. (11/28/12). "Press Release: Roche and the Broad Institute Collaborate to Identify Novel Uses for Advanced Compounds". Nutley, NJ & Cambridge, MA. 2012-11-28
University of Mainz (Johannes-Gutenberg-Universität, JGU). (11/28/12). "Press Release: German Research Foundation Funds New Collaborative Research Center at the Mainz University Medical Center. Focus on Basic Research in Neurosciences Receives Funding of 2012-11-28
Bayer AG. (11/27/12). "Press Release: Bayer Receives Approval for Eylea in Europe for the Treatment of Wet Age-related Macular Degeneration [Not intended for U.S. and UK Media]". Berlin. 2012-11-27
BRAIN AG. (11/27/12). "Press Release: BRAIN Announces € 60m Round of Financing to Expand Its Buy-and-Build Strategy. Raised Capital Earmarked to Help Position BRAIN as a Fully Integrated Industrial Company". Zwingenberg. 2012-11-27
MorphoSys AG. (11/27/12). "Press Release: MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides. MorphoSys to Participate in Lanthio Pharma’s Series A Financing". 2012-11-27
Ruhr-Universität-Bochum. (11/27/12). "Pressemitteilung: Noch mehr Schub für die Proteinforschung im Ruhrgebiet. RUB-Sonderforschungsbereich 642 geht in die dritte Runde – DFG fördert Bochum-Dortmunder Kooperation mit 7,2 Mio. Euro". Bochum. 2012-11-27
Tecan Group Ltd.. (11/27/12). "Press Release: Tecan Launches AlphaScreen Option for Infinite F200 Pro Reader". Männedorf. 2012-11-27
Apitope International N.V.. (11/26/12). "Press Release: Apitope Completes Recruitment into Its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis". Hamburg & Bonn. 2012-11-26
Bayer AG. (11/26/12). "Press Release: Bayer HealthCare Acquires Software Developer Radimetrics Inc. [Not intended for UK Media]". Leverkusen. 2012-11-26
Lanthio Pharma B.V.. (11/26/12). "Press Release: Lanthio Pharma Announces Technology Alliance with MorphoSys AG and Secures Series A Financing". Groningen. 2012-11-26
Evotec AG. (11/23/12). "Press Release: Evotec Receives CIR (French Research Tax Credit) Accreditation". Hamburg. 2012-11-23
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.. (11/23/12). "Pressemitteilung: Max-Planck-Gesellschaft gründet Forschungsgruppe Systemimmunologie in Würzburg. Neue Forschungsgruppe soll Immunabwehr als Gesamtsystem erforschen". 2012-11-23
Kibion AB. (11/23/12). "Press Release: Diabact UBT + IRIS – the Perfect Combination for Helicobacter pylori Diagnosis. Comparison IRIS – Mass Spec". 2012-11-23
Actelion Ltd.. (11/22/12). "Press Release: Actelion Submits the Registration Dossier for Macitentan (Opsumit) to the European Medicines Agency (EMA)". Allschwil. 2012-11-22
Basilea Pharmaceutica Ltd.. (11/22/12). "Press Release: Basilea Initiates Next Phase 1 Multiple Ascending Dose Study with Antibiotic BAL30072 Active against Multidrug-resistant Gram-negative Bacteria". Basel. 2012-11-22
High-Tech Gründerfonds Management GmbH. (11/22/12). "Press Release: Cell Culture Made Easy – InnoCyte GmbH Finds Further Investors". Stuttgart, Bonn & Munich. 2012-11-22
Qiagen N.V.. (11/22/12). "Press Release: Qiagen N.V. Share Repurchase – Interim Reporting (Disclosure according to Art 4 Para 4 of the Regulation (EC) No. 2273/2003)". 2012-11-22
BASF SE. (11/21/12). "Press Release: BASF Announces Cash Offer to Acquire Pronova BioPharma. BASF to Achieve Leading Position in Omega-3 Fatty Acids – Cash Offer of NOK 12.50 per Share". Ludwigshafen. 2012-11-21
Bayer AG. (11/21/12). "Press Release: Merger Agreement Terminated – Bayer Forgoes Proposed Acquisition of Schiff Nutrition International. Bayer Committed to Continue with Bolt-on Acquisition Strategy". Leverkusen. 2012-11-21
Evolva Holding S.A.. (11/21/12). "Press Release: Evolva Selected to Acquire Certain Fluxome Assets". Reinach. 2012-11-21
ViruSure GmbH. (11/21/12). "Press Release: Sekisui Medical, Japan, and ViruSure Agree Marketing Cooperation in Japan. Offering Biosafety Testing Expertise for Japan’s Biopharmaceutical Companies". Tokyo. 2012-11-21
Thermo Fisher Scientific Inc.. (11/20/12). "Press Release: Thermo Fisher Scientific Enters into a Long-term Agreement with Fujirebio Inc. to Strenghten Availability of Biomarker Procalcitonin (PCT)". Hennigsdorf. 2012-11-20
Novartis AG. (11/20/12). "Press Release: Novartis Receives FDA Approval for Flucelvax, the First Cell-culture Vaccine in US to Help Protect against Seasonal Influenza". Basel. 2012-11-20
BioCat GmbH. (11/19/12). "Press Release: BioCat and ALPCO Diagnostics Sign Exclusive Distribution Agreement". Heidelberg. 2012-11-19
Biofrontera AG. (11/19/12). "Press Release: Biofrontera Publishes Interim Report for the 3rd Quarter of 2012". Leverkusen. 2012-11-19
DKFZ (Deutsches Krebsforschungszentrum). (11/16/12). "Press Release: Sciene and Industry Join Forces to Optimize Cancer Treatment". 2012-11-16
Evotec AG. (11/15/12). "Press Release: Evotec Partners with Haplogen to Develop Drugs for Infectious Diseases". Hamburg & Vienna. 2012-11-15
Anagnostics Bioanalysis GmbH. (11/15/12). "Pressemitteilung: Sepsis – Ein Test-System für Ursachendiagnose und Therapieverlauf. Markteintritt eines integrierten Sepsis-Tests sichert lebensrettenden Zeitvorsprung". 2012-11-15
Definiens AG. (11/15/12). "Press Release: Definiens Appoints Dr. Gerald Möller as Chairman of Its Supervisory Board". Munich. 2012-11-15
Merck KGaA. (11/15/12). "Press Release: Q3 2012. Merck’s Good Performance Continues During Transformation". Darmstadt. 2012-11-15
Tecan Group Ltd.. (11/15/12). "Press Release: Tecan and Promega Offer Variable Volume DNA Isolation. The Freedom EVO – HSM Is a Turnkey Solution for gDNA Extraction". Männedorf. 2012-11-15
Almirall S.A.. (11/15/12). "Press Release: 3rd Quarter Results. Q3 in Line, Eklria Now Availalbe to European Patients". Barcelona. 2012-11-15
Genedata AG. (11/14/12). "Press Release: LifeTech TaqMan Assays Integrate with Genedata Expressionist for Genomic Profiling. Genedata Partners with Life Technologies to Expedite NGS Data Analysis and Real-time PCR-based Validation". Basel. 2012-11-14
Sygnis Pharma AG. (11/14/12). "Press Release: Sygnis Announces Six Months Results of Fiscal Year 2012". Heidelberg. 2012-11-14
Alacris Theranostics GmbH. (11/14/12). "Press Release: Alacris Theranostics Enters Agreement with GSK to Use ModCell System for Early Stage Cancer Research". Berlin. 2012-11-14
Ionicon Analytik GmbH. (11/13/12). "Press Release: RJ Lee Group’s Mobile Lab Including Ioncion PTR-MS Is Now Deployed for Real-time VOCs Monitoring". 2012-11-13
Biotest AG. (11/13/12). "Press Release: Biotest Increases EBT Significantly by 26%". Dreieich. 2012-11-13
Boehringer Ingelheim. (11/13/12). "Press Release: Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT High Pressure Protein Refolding Technology". Ingelheim & Aurora, CO. 2012-11-13
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen. (11/13/12). "Pressemitteilung: GO-Bio-Preis für neue Biomarkertests. Forscherteam des NMI Reutlingen ausgezeichnet". 2012-11-13
next pagenext page 1 2 3 ... 63 64 65 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top